XML 28 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities      
Net income $ 35,450 $ 79,219 $ 54,854
Adjustments to reconcile net income to net cash provided by operating activities      
Depreciation, amortization and accretion 156,947 141,089 115,716
Deferred tax expense (benefit) 12,500 (61,959) (188)
Tax receivable agreements expense 836 38,187  
(Gain) loss on disposal of property and equipment and divestitures (3,255) 210 (2,192)
Equity in losses of unconsolidated entities 352 1,800 913
Credit loss expense 58 5,191 2,023
Amortization of debt issuance costs 489 489 661
Inventory adjustments (638) 2,349 (737)
Equity-based compensation 26,358 17,369 15,570
Impairments and abandonments 1,237 12,607  
Bargain purchase gain     (13,352)
Other operating items, net 1,093 (450) (1,714)
Changes in operating assets and liabilities      
Accounts receivable 46,883 102,300 (162,257)
Prepaid expenses and other assets (14,590) (6,729) 1,229
Accounts payable and accrued liabilities (28,834) (46,317) 22,705
Net cash provided by operating activities 234,886 285,355 33,231
Cash flows from investing activities      
Proceeds received from divestitures     1,700
Purchase of property and equipment (173,153) (135,866) (71,884)
Purchase of equity-method investments   (500) (7,667)
Collection of note receivable     184
Distribution from cost method investment     60
Acquisitions, net of cash and restricted cash received (161,279) (17,693) (6,959)
Proceeds received from sales of property and equipment 15,809 16,891 31,320
Net cash used in investing activities (318,623) (137,168) (53,246)
Cash flows from financing activities      
Borrowings from revolving line of credit 165,000 105,250 143,000
Payments on revolving line of credit (80,000) (121,250) (127,000)
Payments on current and long-term debt     (22,075)
Payments of finance lease obligations (231) (98) (112)
Payment of debt issuance costs     (2,144)
Dividends and distributions paid (29,745) (24,924) (6,020)
Proceeds from share issuance 50   53
Payments under tax receivable agreements (521)    
Distributions to noncontrolling interests   (1,581) (1,943)
Purchase of noncontrolling interests     (22,000)
Contributions from noncontrolling interests   5,950  
Repurchase of common stock (7,912) (61,770) (20,210)
Net cash provided by (used in) financing activities 46,641 (98,423) (58,451)
Effect of exchange rate changes on cash (9) (3) (13)
Net (decrease) increase in cash and cash equivalents (37,105) 49,761 (78,479)
Cash and cash equivalents, beginning of period 57,083 7,322 85,801
Cash and cash equivalents, end of period 19,978 57,083 7,322
Supplemental cash flow disclosure:      
Cash paid for interest 7,138 4,705 1,970
Cash paid for income taxes, net 1,819 1,651 (452)
Supplemental disclosure of noncash operating activities:      
Asset retirement obligation revisions 12,290    
Lease liabilities arising from obtaining right-of-use assets 12,581 7,581 14,778
Supplemental disclosure of noncash investing activities:      
Recoupment of shares for acquisitions   (410) 133,646
Conversion of notes receivable to equity-method investment     4,442
Capital expenditures included in accounts payable and accrued liabilities $ 50,016 $ 34,480 17,789
Supplemental disclosure of noncash financing activities:      
Accrued contributions from noncontrolling interests     4,797
Issuance of shares for NCI acquisitions     $ 7,313